Cipla Limited
V/S
Sun Pharmaceutical Industries Ltd
Introduction:
The case study is about the illegal use of a trademark by Sun Pharmaceutical Industries Ltd., while another company (Cipla Limited) was already using that trademark. Cipla Limited filed a case against Sun Pharmaceutical Industries Ltd. for infringement.
Backgrounds of companies:
Sun Pharmaceutical Industries Ltd. is an Indian multinational pharmaceutical company. Which is located in Mumbai, Maharashtra. It makes and sells pharmaceutical ingredients in more than 100 countries across the globe.
Cipla Limited is an Indian multinational pharmaceutical company. Which is located in Mumbai, Maharashtra. It manufactures medicine to treat respiratory disease, cardiovascular disease, diabetes, and various other medical conditions.
The case:
The mark “Respule” is owned by Cipla Ltd Company. It has been in use since 2013. Cipla had been selling medicines that treat respiratory ailments under the names Budecort Respules and Duolin Respules. But Sun Pharma had been illegally using the mark “Respule” and has falsely copied the trade dress, packaging, and label.
| Cipla |
Budecort Respules & Duolin Respules
V/S
|
SUN Pharma |
Budesonide Respules & DUOZ 2.5ML RESPULES
Observation of the Court:
The court observed that Sun Pharma has copied Cipla in the form of trade dress, packaging, and labels, intending to take advantage of the demand in the market for these medicines, even to adopt the goodwill and reputation of Cipla Limited.
Even the court has declared that if Cipla Limited permits to release of the products in the market due to public need in the country so that Sun Pharma can release the products, it would be non-calculated damage to Cipla.
Decision:
In favor of Cipla Limited, the Court has dismissed the applications filed by Sun Pharma, which were using the trademark “RESPULES.”
At PATHtoIP®, we ensure that every client receives exceptional results through high-quality Intellectual Property research. As an experienced firm, we are dedicated to providing IP protection and delivering results capable of reaching your goals.
MORE
The Cipla Limited v. Sun Pharmaceutical Industries Ltd. case is a significant example of how intellectual property rights influence competition and innovation in the pharmaceutical industry. The dispute highlights the importance of patent protection, regulatory compliance, and effective enforcement of intellectual property rights in safeguarding pharmaceutical innovations.
MORE Case Study : The Coca-Cola Company v. Bisleri International Pvt. Ltd. case is a landmark trademark dispute that highlights the significance of trademark ownership, assignment agreements, and brand protection under intellectual property law. The case arose from disagreements over the rights associated with the MAAZA trademark following its transfer through a trademark assignment agreement.
Who We Are
At PATHtoIP, we believe every innovative idea deserves the right protection and the opportunity to create a lasting impact. We are a leading Intellectual Property (IP) consulting firm dedicated to helping innovators, startups, SMEs, researchers, academic institutions, and enterprises transform ideas into valuable intellectual assets.
Our expertise spans patents, trademarks, copyrights, industrial designs, patent analytics, freedom-to-operate (FTO) studies, white space analysis, technology landscaping, and comprehensive IP portfolio management. By combining technical knowledge with legal and business insights, we deliver practical IP strategies that support innovation, commercialization, and sustainable business growth.
Our mission is to empower creators and businesses with the confidence to innovate, compete, and grow in an increasingly knowledge-driven economy. Whether you’re launching your first invention or managing an established IP portfolio, PATHtoIP is committed to helping you secure, protect, and maximize the value of your intellectual property.
Stay connected with PATHtoIP for the latest insights on patents, trademarks, copyrights, innovation, and IP strategy. Follow us on Facebook, X , Pinterest, YouTube, and Quora for expert guidance, industry updates, case studies, and practical tips to protect your innovations.
